Certolizumab pergola (Cimzia)

A biologic rheumatoid arthritis (RA) medication for adults with moderately to severely active RA.

Reduces RA inflammation.

Also approved for Crohn’s disease.

Targets TNF-alpha.

In clinical trials provides noticeable RA symptom relief within 24 weeks for the majority of patients and as fast as 1-2 weeks for some patients.

The recommended dose for adults with RA is 400 mg (given as 2 shots that are 200 mg each) initially and at Week 2 and Week 4.

After the first 3 doses, taken as one 200 mg shot every 2 weeks or two 200 mg shots every 4 weeks.

Leave a Reply

Your email address will not be published. Required fields are marked *